deltatrials
Unknown OBSERVATIONAL NCT03263832

Evaluation of the Antibiofilmogramme Test During Orthopaedic Device-Related Infection (BJIBiofilm)

Demonstration of Clinical Value of Antibiofilmogramme Test for Monomicrobial S. Aureus Orthopaedic Device-Related Infection

Sponsor: BioFilm Control

Interventions Antibiofilmogramme
Updated 15 times since 2017 Last updated: Mar 1, 2021 Started: Jun 1, 2015 Primary completion: Feb 28, 2018 Completion: Dec 1, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Biofilm and Prosthetic Joint Infection and is currently ongoing. BioFilm Control leads this study, which shows 15 recorded versions since 2015 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Study Description(click to expand)

The secondary objectives are: A. Investigate the role of antibiogram-antibiofilmogramme concordance (in terms of S. aureus strains and prescribed antibiotics) in orthopaedic device-related infection management. B. Investigate the capacity of S. aureus isolates to form biofilm in presence/absence of antibiotics. C. Create an S. aureus strain collection for future ancillary studies

The secondary objectives are:

A. Investigate the role of antibiogram-antibiofilmogramme concordance (in terms of S. aureus strains and prescribed antibiotics) in orthopaedic device-related infection management.

B. Investigate the capacity of S. aureus isolates to form biofilm in presence/absence of antibiotics.

C. Create an S. aureus strain collection for future ancillary studies

Status Flow

~Sep 2017 – ~Mar 2018 · 6 months · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Aug 2020 · 24 months · monthly snapshot~Aug 2020 – ~Nov 2020 · 3 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Dec 2021 · 8 months · monthly snapshot~Dec 2021 – ~Apr 2023 · 16 months · monthly snapshot~Apr 2023 – ~Jul 2024 · 15 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 19 months · monthly snapshot~Jan 2026 – present · 3 months · monthly snapshot

Change History

15 versions recorded
  1. Jan 2026 — Present [monthly]

    Unknown

  2. Sep 2024 — Present [monthly]

    Unknown

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown StatusUnknown

  4. Apr 2023 — Jul 2024 [monthly]

    Unknown Status

    Status: Active Not RecruitingUnknown Status

  5. Dec 2021 — Apr 2023 [monthly]

    Active Not Recruiting

Show 10 earlier versions
  1. Apr 2021 — Dec 2021 [monthly]

    Active Not Recruiting

    Status: Unknown StatusActive Not Recruiting

  2. Jan 2021 — Apr 2021 [monthly]

    Unknown Status

  3. Nov 2020 — Jan 2021 [monthly]

    Unknown Status

  4. Aug 2020 — Nov 2020 [monthly]

    Unknown Status

    Status: Active Not RecruitingUnknown Status

  5. Aug 2018 — Aug 2020 [monthly]

    Active Not Recruiting

    Status: RecruitingActive Not Recruiting

  6. Jun 2018 — Aug 2018 [monthly]

    Recruiting

  7. May 2018 — Jun 2018 [monthly]

    Recruiting

  8. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NANone

  9. Mar 2018 — Apr 2018 [monthly]

    Recruiting NA

  10. Sep 2017 — Mar 2018 [monthly]

    Recruiting NA

    First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • BioFilm Control
  • Hospices Civils de Lyon
Data source: BioFilm Control

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations